Key takeaway: The investor presentation for Artemis Medicare Services Limited for Q1 FY 27 reported a revenue from operations of INR 28,732 Lacs, reflecting a 12.7% year-over-year increase. EBITDA rose by 27.9% to INR 6,182 Lacs, with an EBITDA margin of 21.5%, up from 19.0% in the previous year. The presentation highlighted a significant PAT growth of 48.3% to INR 3,144 Lacs, with a diluted EPS of INR 1.98, marking a 46.7% increase. Operationally, inpatient volumes increased by 11.4% year-over-year to 9,181, and bed occupancy improved to 65.7%. The document emphasized the company's strategic growth initiatives, including the operationalization of a 300+ bed super specialty hospital in Raipur and plans for further capacity expansion. Management noted a strong financial track record with consistent earnings growth and industry-leading operating metrics.

Key takeaway: Artemis Medicare Services Limited held its Q4 and FY26 earnings conference call on May 11, 2026, where management provided an overview of the healthcare sector and the company's performance. For FY26, the company reported consolidated revenue of INR 1,081 crores, a 15.4% increase year-on-year, driven by strong performances in cardiology, oncology, and orthopaedics. EBITDA was INR 218 crores with a margin of 20.2%, and profit after tax rose by 26.2% to INR 104 crores. In Q4 FY26, revenue reached INR 279 crores, up 16.4%, with a profit after tax of INR 30 crores, reflecting a 32.1% increase. Management highlighted ongoing expansion plans, including a new 300-bed hospital in Raipur and a 650-bed facility in South Delhi, and emphasized their commitment to operational efficiency and digital transformation. The company also noted a growing international patient base despite geopolitical challenges.

Key takeaway: The investor presentation for Artemis Medicare Services Limited for Q4 FY 26 and FY 26 reported a revenue from operations of INR 27,923 Lacs for Q4 FY 26, reflecting a year-on-year growth of 16.4%. For FY 26, the revenue reached INR 1,08,124 Lacs, a 15.4% increase compared to FY 25. EBITDA for Q4 FY 26 was INR 5,938 Lacs, up 23.1% year-on-year, with an EBITDA margin of 21.3%. The presentation highlighted a PAT of INR 3,028 Lacs for Q4 FY 26, marking a 32.1% increase from the previous year. The company also noted an increase in inpatient volumes and average revenue per occupied bed (ARPOB). Additionally, Artemis Hospitals plans to expand its capacity, including a new 300+ bed super-specialty hospital in Raipur and a 650+ bed facility in South Delhi. The presentation included a detailed overview of financial performance and strategic growth initiatives.

Key takeaway: Artemis Medicare Services Limited held its earnings conference call on February 3, 2026, to discuss its operational and financial performance for Q3 and 9M FY26. Management reported a consolidated revenue of INR 272 crores for Q3, reflecting a year-on-year growth of 17.2%, driven by strong patient volumes and an improved payer mix. EBITDA for the quarter was INR 52 crores, with a margin of 9.1%. The company also noted a profit after tax of INR 22 crores, up 7.9% year-on-year. For the nine months of FY26, consolidated revenues reached INR 802 crores, a 15.1% increase. Management highlighted ongoing capacity expansions, including a new 300-bed hospital in Raipur and a 650-bed facility in South Delhi, with plans to increase total bed capacity to 2,300 by 2029. The call included discussions on international patient revenue growth and strategic initiatives in digital transformation and sustainability.

Key takeaway: The investor presentation for Artemis Medicare Services Limited reported financial performance for Q3 and 9M FY 26, highlighting a revenue from operations of INR 27,235 Lacs for Q3 FY 26, representing a 17.2% year-over-year growth, and INR 80,202 Lacs for 9M FY 26, a 15.1% increase. EBITDA for Q3 FY 26 was INR 5,203 Lacs, up 12.5% YoY, while PAT was reported at INR 2,223 Lacs, a 7.9% increase. The presentation outlined strategic growth initiatives, including plans for a 650+ bed super-specialty hospital in South Delhi and a 300+ bed facility in Raipur. The company also indicated a goal to raise approximately INR 700 crore to support growth and capital requirements. The shareholding pattern as of December 31, 2025, showed promoters holding 58.4% of shares. Overall, the document emphasized growth in revenue and operational capacity.